arrow
M

Michael Lock

lawson health sciences research institute
H指数:42
被引数:9,769

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial

PSMA PET和MRI引导下前列腺SABR联合同步局部加量的两年随访结果:ARGOS-CLIMBER 1/2期试验的简要报告

2026-09-150
OA
Determining Optimal Fractionation of Neoadjuvant Radiation in Low-Risk, Early-Stage Breast Cancer—Randomized SIGNAL Clinical Trial

确定低风险,早期乳腺癌新辅助放疗的最佳分割-随机信号临床试验

Cancers
IF4.4
2026-06-080
OA
Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration-resistant prostate cancer in Canada (GROUQ-PCS 9): a multicentre, open-label, randomised, phase 2 trial

在加拿大对寡转移性去势抵抗性前列腺癌进行转移灶导向治疗联合标准系统性治疗(GROUQ-PCS 9):一项多中心、开放标签、随机、Ⅱ期临床试验

2025-09-010
PRE
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial
2025-01-012
PRE
Ablative Radiation Therapy to Restrain Everything Safely Treatable (ARREST): A Phase 1 Study of Stereotactic Ablative Radiation Therapy for Polymetastatic Disease
2024-12-012
PRE
Barrier films or dressings for the prevention of acute radiation dermatitis in breast cancer: a systematic review and network meta-analysis
2024-08-070
PRE